Paper7513616
Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
Cross AH and 2 others. Cell Immunol, 1993. Cited by 89 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Papers, record 7513616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7513616
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Encephalomyelitis, Autoimmune, Experimental | Major topic |
| Myelin Proteins | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Chronic Disease | |
| Female | |
| Immunotherapy, Adoptive | |
| Lymphocyte Activation | |
| Mice | |
| Molecular Sequence Data | |
| Myelin Basic Protein | |
| Myelin Proteolipid Protein | |
| Peptide Fragments | |
| Recurrence |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| NS 08952 | NINDS NIH HHS | United States | R01NS008952 | PubMed and NIH | NIH RePORTER |
| NS 11920 | NINDS NIH HHS | United States | P01NS011920 | PubMed and NIH | NIH RePORTER |
| NS 29095 | NINDS NIH HHS | United States | R29NS029095 | PubMed and NIH | NIH RePORTER |
| P50NS011920 | NIH | NIH RePORTER |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27423965 | Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein. | J Neuroimmunol | 2016 | https://conductscience.org/library/papers/27423965 | PubMed |
| 25267971 | Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread. | J Immunol | 2014 | https://conductscience.org/library/papers/25267971 | PubMed |
| 18674593 | Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. | Neuroscience | 2009 | https://conductscience.org/library/papers/18674593 | PubMed |
| 9836383 | Oral tolerance and the treatment of rheumatoid arthritis. | Springer Semin Immunopathol | 1998 | https://conductscience.org/library/papers/9836383 | PubMed |
| 9120012 | Diversity and plasticity of self recognition during the development of multiple sclerosis. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9120012 | PubMed |
| 9104817 | Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. | J Exp Med | 1997 | https://conductscience.org/library/papers/9104817 | PubMed |
| 8994863 | Epitope spreading. | Curr Opin Immunol | 1996 | https://conductscience.org/library/papers/8994863 | PubMed |
| 8833909 | Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8833909 | PubMed |
| 8675668 | Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. | J Clin Invest | 1995 | https://conductscience.org/library/papers/8675668 | PubMed |
| 8666934 | A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. | J Exp Med | 1996 | https://conductscience.org/library/papers/8666934 | PubMed |
| 8022835 | Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8022835 | PubMed |
| 7971958 | Oral tolerance. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7971958 | PubMed |
| 7540658 | Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. | J Exp Med | 1995 | https://conductscience.org/library/papers/7540658 | PubMed |
| 7539461 | Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7539461 | PubMed |
| 7528355 | Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review. | Neurochem Res | 1994 | https://conductscience.org/library/papers/7528355 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MBP | 4155 | PubTator's text mining | https://conductscience.org/library/genes/4155 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7513616
GET https://conductscience.org/api/papers/v1/7513616/authors